By Dr. Rajat Kandhari — MD Dermatology (Gold Medalist), MSc Non-Surgical Facial Aesthetics (Distinction, UK), Medical Director, Dr. Kandhari’s Skin Clinic, Greater Kailash Part-1, South Delhi
Persistent facial redness is one of the most consistently misdiagnosed conditions at our Greater Kailash Part-1 clinic. Patients arrive having been told they have sensitive skin, allergic skin, or a reaction to their skincare — having switched products repeatedly without improvement, having been prescribed topical steroids that initially helped and then made things dramatically worse, and having been managing what is actually rosacea as if it were simply an irritated complexion. The problem with this mismanagement is not just cosmetic. Rosacea is a chronic inflammatory vascular and neurovascular condition — without correct diagnosis and targeted treatment, it progresses. The flushing becomes more frequent and more intense. The background redness becomes permanent. The papulopustular component worsens. And in some patients — particularly men — the skin of the nose thickens progressively into rhinophyma, a change that requires surgical correction rather than medical management.
Correct diagnosis changes this trajectory entirely. This guide explains what rosacea treatment delhi patients need to understand — the clinical subtypes, the triggers that are particularly relevant in the South Delhi environment, and the treatments that actually address the underlying mechanisms.
Key Takeaways
- Rosacea Has Four Subtypes: Erythematotelangiectatic rosacea, papulopustular, phymatous, and ocular — each has different presentations and requires different treatment approaches.
- Topical Steroids Make Rosacea Worse: The single most common management error — short-term improvement followed by significant rebound, dependency, and worsening of the vascular component.
- Demodex Mites Are a Key Driver: Overpopulation of Demodex mite in rosacea skin is a significant inflammatory trigger — topical ivermectin addresses this specifically.
- Delhi’s Environment Is Particularly Rosacea-Unfriendly: Heat, UV, spicy food, stress, and pollution are all established rosacea triggers — all abundant in South Delhi’s urban environment.
- PDRN and Vascular Laser Are the In-Clinic Treatments: PDRN reduces the chronic dermal inflammation driving rosacea; vascular laser addresses established telangiectasia and persistent erythema.
What Rosacea Is — and Why It Is Not Just Sensitive Skin
Rosacea is a chronic, relapsing-remitting inflammatory condition of the facial skin characterised by vascular hyperreactivity, neurovascular dysregulation, and — in many patients — an inflammatory response to Demodex mite overpopulation and disrupted skin barrier function. It is not simply sensitive skin, though it does produce skin sensitivity as one of its features. The distinction matters because treating sensitivity without addressing the underlying vascular and inflammatory drivers produces only partial, temporary improvement.
The prevalence of rosacea in South Delhi is likely higher than recognised — partly because the condition is underdiagnosed on Fitzpatrick type IV–VI Indian skin, where the erythema component can be less visually prominent against a darker baseline skin tone and may be dismissed as normal variation, and partly because patients with papulopustular rosacea are frequently misdiagnosed as having acne and treated with antibiotics that address the pustules without managing the underlying vascular and inflammatory drivers.
The Four Clinical Subtypes of Rosacea
1. Erythematotelangiectatic Rosacea (ETR)
Erythematotelangiectatic rosacea is the most common subtype — presenting as persistent central facial redness (cheeks, nose, chin, central forehead), episodic flushing that is more intense than normal blushing and lasts longer, visible telangiectasia (fine red blood vessels visible at the skin surface), and skin sensitivity with stinging or burning in response to products that would not cause this in normal skin. Flushing episodes are triggered by heat, exercise, alcohol, spicy food, emotional stress, and UV — all significant triggers in the South Delhi environment.
The mechanism involves TRPV1 neurogenic flushing — activation of transient receptor potential vanilloid 1 channels in cutaneous nerve endings, which release neuropeptides that trigger mast cell degranulation and vasodilation. This is why spicy food (capsaicin is a potent TRPV1 agonist) and heat are such consistent triggers. Over time, repeated flushing episodes cause progressive damage to the vessel walls — the telangiectasia becomes permanent even between episodes.
2. Papulopustular Rosacea
Papulopustular rosacea presents as inflammatory papules and pustules on a background of central facial erythema — the presentation most likely to be confused with acne. The key distinguishing features are: the lesions occur on a background of diffuse redness rather than the normal skin seen in acne; there are no comedones (blackheads or whiteheads) — a definitive feature distinguishing rosacea from acne; the lesions are predominantly in the central face; and patients are typically in their 30s to 50s rather than the teenage or early adult acne demographic.
The Demodex mite rosacea connection is strongest in this subtype. Demodex folliculorum mites live in the hair follicles of normal facial skin in almost all adults, but in rosacea patients — particularly papulopustular rosacea — mite density is significantly elevated. The mites carry bacteria (Bacillus oleronius) that trigger an inflammatory response in the follicle, contributing to the papule and pustule formation. This is why topical ivermectin — which is antiparasitic and reduces Demodex density — produces significant improvement in papulopustular rosacea.
3. Phymatous Rosacea
Phymatous rosacea represents chronic, progressive thickening of the skin and subcutaneous tissue — most commonly on the nose (rhinophyma), but also affecting the chin, forehead, and ears. It is significantly more common in men. Rhinophyma produces a bulbous, irregular nasal appearance with enlarged follicles and a rough surface texture. In early stages, medical treatment can slow progression. Established rhinophyma requires surgical management — laser ablation or surgical recontouring — to achieve meaningful improvement.
4. Ocular Rosacea
Ocular rosacea affects approximately 50% of rosacea patients, though it is frequently unrecognised. It presents as lid margin inflammation (blepharitis), conjunctival injection, dry eye, photosensitivity, and — in severe cases — corneal involvement. Patients with rosacea who experience persistent eye symptoms should mention them at their dermatology consultation — ocular rosacea is managed in conjunction with ophthalmology when corneal involvement is present.
Rosacea Triggers in the South Delhi Context
Rosacea trigger management is a cornerstone of treatment — reducing trigger exposure reduces flare frequency and intensity, and makes medical treatment more effective by reducing the baseline inflammatory load. South Delhi’s environment is particularly challenging for rosacea patients because it concentrates multiple major triggers simultaneously:
- UV exposure: One of the most consistent rosacea triggers — UV activates TRPV1 channels and directly stimulates facial vasodilation. Delhi’s extreme UV index for most of the year means that inadequate sun protection is a continuous flushing trigger. Broad-spectrum SPF 50+ every morning is a clinical requirement, not a cosmetic recommendation, for all rosacea patients.
- Heat: Ambient heat directly triggers TRPV1 neurogenic flushing. Delhi’s summer months (April–June) with temperatures regularly exceeding 40°C represent a sustained, high-intensity flushing trigger. Air conditioning helps, but rapid transition between extreme heat outdoors and cold indoor environments also triggers episodes.
- Spicy food: Spicy food flushing via capsaicin TRPV1 activation is a significant and consistent trigger in the South Delhi patient population, where spicy food is a dietary staple. Patients do not need to eliminate spicy food entirely — identifying their personal threshold and managing episodes with trigger awareness is a more realistic management goal.
- Stress: Psychological stress activates the hypothalamic-pituitary-adrenal axis and releases neuropeptides that drive facial vasodilation — a particularly relevant trigger in South Delhi’s high-pressure professional environment.
- Alcohol: Ethanol is a direct vasodilator and TRPV1 activator — even small amounts trigger significant flushing in many rosacea patients. Red wine is typically a stronger trigger than white wine or spirits.
- Skincare products: Alcohol-containing toners, fragrance, certain preservatives, and physical exfoliants all trigger rosacea flares by disrupting the already-compromised skin barrier. Simplifying the routine to gentle, fragrance-free, barrier-supporting products reduces product-triggered episodes significantly.
Why Topical Steroids Make Rosacea Worse
The most common and most damaging error in rosacea management — seen consistently in patients presenting to our rosacea doctor GK1 clinic after self-management or management elsewhere — is the use of topical corticosteroids. Topical steroids provide rapid, visible improvement in rosacea-related redness and inflammation through vasoconstriction and anti-inflammatory action. This improvement is temporary and dependency-forming: the moment the steroid is reduced or stopped, the underlying vascular hyperreactivity — now sensitised — rebounds more intensely than before. Patients then increase the frequency of steroid application to control the rebound, creating a cycle of dependency that progressively worsens the vascular component of the disease.
Perioral dermatitis — a rosacea-like eruption around the mouth — is specifically caused and worsened by topical steroid application. Any patient whose facial redness has been managed with topical steroids needs a structured steroid withdrawal protocol under dermatologist supervision before targeted rosacea treatment can begin.
Medical Treatment: What Works and How It Is Used
Topical Ivermectin
Topical ivermectin metronidazole — specifically ivermectin 1% cream — is currently the most evidence-supported topical treatment for papulopustular rosacea. It addresses the Demodex mite density that drives follicular inflammation, reduces the inflammatory cytokine activity in the dermis, and produces sustained improvement in both papule/pustule count and background erythema with once-daily application. Clinical trials show superiority over topical metronidazole for papulopustular rosacea — making it the preferred first-line topical for this subtype. Topical metronidazole remains effective for milder papulopustular and for maintenance.
Topical Brimonidine
Brimonidine topical (0.33% gel) is an alpha-2 adrenergic agonist that directly constricts cutaneous blood vessels, providing rapid and visible reduction in facial erythema within 30 minutes of application. It is used for the erythema and flushing of erythematotelangiectatic rosacea — it does not treat the underlying vascular hyperreactivity but effectively manages the visible redness during the application period (approximately 8–12 hours). It does not treat papules or pustules. Some patients experience rebound erythema as the effect wanes — careful dosing and frequency management minimises this.
Oral Antibiotics: Doxycycline
Low-dose doxycycline (40mg modified-release, subantimicrobial dose) is the standard oral treatment for moderate-to-severe papulopustular rosacea. At this dose, it works through anti-inflammatory mechanisms — specifically inhibiting matrix metalloproteinase activity and reducing inflammatory cytokine production — rather than antibacterial activity. This is why it produces improvement in rosacea at doses that do not cause antibiotic resistance. Courses are typically 12 weeks, with reassessment and topical maintenance thereafter.
In-Clinic Treatments at Our South Delhi Clinic
PDRN — Reducing the Inflammatory Driver
PDRN anti-inflammatory rosacea treatment works through the A2A adenosine receptor pathway — reducing the chronic dermal inflammatory signalling that sustains vascular hyperreactivity and mast cell activation in rosacea-affected skin. Intradermal PDRN injections across the affected central face produce meaningful reduction in baseline redness, flushing frequency, and skin sensitivity over a course of three to four sessions. Unlike vascular laser, PDRN addresses the inflammatory driver rather than the established vessel — making it particularly appropriate for patients in early or active rosacea where the inflammation is the primary problem, before significant permanent telangiectasia has formed. It is also the preferred in-clinic treatment for rosacea patients with darker Fitzpatrick IV–VI skin, where vascular laser requires careful selection and parameter management.
Vascular Laser / IPL for Telangiectasia
For patients with established, permanent telangiectasia — fine red vessels visible on the cheeks and nose that do not resolve between flares — vascular laser or IPL (intense pulsed light) targets the haemoglobin in the vessels selectively, causing them to coagulate and be reabsorbed. This reduces the permanent background redness and the visible vessel network. On Fitzpatrick IV–VI Indian skin, vascular laser requires careful wavelength and parameter selection to avoid inadvertent heating of melanin — a dermatologist with appropriate laser training and experience with Indian skin is essential for this treatment. The QS NdYAG laser, which has been mentioned in other blogs for pigmentation, can also be used in appropriate settings for facial redness management.
Trigger Management and Barrier Rebuilding
These are not secondary considerations — for many patients, trigger identification and barrier repair produce as much improvement as any topical medication. A simplified, fragrance-free routine using gentle cleanser, a barrier-repairing moisturiser (ceramides, niacinamide, azelaic acid — all well-tolerated on rosacea skin), and a physical mineral sunscreen (zinc oxide or titanium dioxide — less irritating to sensitised skin than chemical UV filters) forms the foundation on which all other treatments work.
Rosacea Subtype vs Treatment Approach
| Subtype | First-Line Medical | In-Clinic Treatment | Key Trigger to Address |
|---|---|---|---|
| Erythematotelangiectatic | Brimonidine topical, SPF | Vascular laser / PDRN | UV, heat, alcohol, spicy food |
| Papulopustular | Topical ivermectin, low-dose doxycycline | PDRN, gentle peels | Demodex density, barrier disruption |
| Phymatous | Oral isotretinoin (early stage) | CO2 laser recontouring, surgical | Early intervention; prevent progression |
| Ocular | Lid hygiene, topical cyclosporine eye drops | Dermatology + ophthalmology co-management | Eye rubbing, dry air, contact lens use |
“Rosacea cannot be cured — but it can be very effectively controlled. The patients who do best are those who understand their triggers, follow a consistent simplified routine, and treat flares early rather than waiting for significant progression before seeking help.” — Dr. Rajat Kandhari
For a rosacea assessment and personalised treatment plan in South Delhi, book a consultation at Dr. Rajat Kandhari’s clinic.
S-79, Greater Kailash Part-1, New Delhi 110048 | Monday–Saturday, 9am–8pmCall or WhatsApp: +91 9315479193
Frequently Asked Questions
Q1. How do I know if I have rosacea or just sensitive skin?
The key distinguishing features of rosacea are: persistent central facial redness that does not fully resolve between episodes; episodic flushing that is disproportionate to the trigger and lasts longer than normal blushing; visible telangiectasia on the cheeks or nose; and in papulopustular rosacea, inflammatory papules and pustules on a background of redness without comedones. Sensitive skin is a skin characteristic — rosacea is a clinical condition with specific diagnostic features. A dermatologist examination distinguishes them definitively.
Q2. Can rosacea be cured?
Rosacea is a chronic condition — there is currently no cure that permanently eliminates the underlying vascular hyperreactivity. However, it is very effectively controlled with appropriate treatment and trigger management. Most patients achieve sustained periods of minimal symptoms with the right combination of topical treatment, trigger avoidance, and in-clinic procedures. Progression to phymatous rosacea is largely preventable with early, consistent management.
Q3. Why did my rosacea get worse after using a steroid cream?
Topical corticosteroids cause initial improvement in rosacea through vasoconstriction and anti-inflammatory action — followed by rebound vasodilation and worsened vascular hyperreactivity when the steroid is reduced or stopped. Repeated use creates dependency and progressive worsening of the underlying vascular component. Rosacea should never be managed with topical steroids — if you have been using them, a supervised withdrawal protocol is needed before targeted rosacea treatment can begin.
Q4. Is rosacea common on Indian skin?
Rosacea occurs in Indian Fitzpatrick IV–VI skin but is underdiagnosed because the erythema component is less visually obvious against a darker skin tone. Papulopustular rosacea in particular is frequently misdiagnosed as acne in Indian patients. The absence of comedones — present in acne, absent in rosacea — is the key distinguishing feature. A dermatologist experienced with darker skin types makes this distinction reliably.
Q5. What skincare ingredients are safe for rosacea-prone Indian skin?
The safest and most beneficial ingredients for rosacea on Indian skin are: niacinamide (anti-inflammatory, barrier-supporting, well-tolerated), azelaic acid (reduces inflammation and papule formation, safe on Indian skin), ceramides (barrier repair), and mineral sunscreen (zinc oxide or titanium dioxide — less irritating than chemical UV filters). Avoid: alcohol-containing toners, fragranced products, physical scrubs, strong AHAs, and any product that causes stinging or burning on application.
Q6. How does PDRN help rosacea?
PDRN reduces the chronic dermal inflammatory environment that drives rosacea’s vascular hyperreactivity — through A2A adenosine receptor activation that dampens inflammatory cytokine signalling and mast cell activity. It is particularly useful for rosacea patients on Fitzpatrick IV–VI Indian skin where vascular laser carries more complexity, and for patients in active inflammatory stages where reducing the driver is the priority before addressing established vessels.
Q7. Where is the clinic located?
S-79, Greater Kailash Part-1, New Delhi 110048. Accessible from Hauz Khas, Defence Colony, Green Park, Lajpat Nagar, Malviya Nagar, and Saket. Monday to Saturday, 9am to 8pm. +91 9315479193.